• 1. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 2. Aggregation, pretransitional behavior, and optical properties in the isotropic phase of lyotropic chromonic liquid crystals studied in high magnetic fields
  Tanya Ostapenko,Peter J. Collings,Samuel N. Sprunt,J. T. Gleeson Soft Matter, 2013,9, 9487-9498
• 3. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 4. Aggregation kinetics and gel formation in modestly concentrated suspensions of oppositely charged model ceramic colloids: a numerical study
  M. A. Piechowiak,A. Videcoq,R. Ferrando,D. Bochicchio,C. Pagnoux,F. Rossignol Phys. Chem. Chem. Phys., 2012,14, 1431-1439
• 5. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrazines Pyrazine carboxylic acids and derivatives

Introduction to 5-hydroxypyrazine-2-carboxylic acid; sodium salt (CAS No. 77168-77-5)

5-hydroxypyrazine-2-carboxylic acid; sodium salt, with the chemical formula C?H?NO?Na, is a significant compound in the field of pharmaceutical and biochemical research. This compound, identified by its CAS number CAS No. 77168-77-5, has garnered attention due to its versatile applications and structural properties that make it a valuable intermediate in the synthesis of various pharmacologically active molecules.

The< strong>5-hydroxypyrazine-2-carboxylic acid; sodium salt is a derivative of pyrazine, a heterocyclic aromatic compound that serves as a fundamental scaffold in medicinal chemistry. The presence of both hydroxyl and carboxylic acid functional groups, along with the sodium salt form, enhances its solubility and reactivity, making it an excellent candidate for further chemical modifications and biological evaluations.

In recent years, there has been a surge in research focusing on the development of novel therapeutic agents derived from pyrazine derivatives. The< strong>5-hydroxypyrazine-2-carboxylic acid; sodium salt has been investigated for its potential role in modulating various biological pathways. Its structural features allow it to interact with biological targets in multiple ways, which is crucial for the design of drugs with high specificity and low toxicity.

One of the most compelling aspects of this compound is its utility as a building block in the synthesis of more complex molecules. For instance, researchers have utilized< strong>5-hydroxypyrazine-2-carboxylic acid; sodium salt to develop inhibitors targeting enzymes involved in inflammatory responses. These inhibitors have shown promise in preclinical studies, suggesting their potential as therapeutic agents for conditions such as rheumatoid arthritis and inflammatory bowel disease.

The< strong>sodium salt form of this compound is particularly advantageous due to its enhanced stability and solubility compared to the free acid form. This property makes it more suitable for formulation into pharmaceutical products and enhances its bioavailability upon administration. Additionally, the sodium counterion can influence the compound's pharmacokinetic profile, potentially leading to improved therapeutic efficacy.

Recent advancements in computational chemistry have also highlighted the< strong>5-hydroxypyrazine-2-carboxylic acid; sodium salt as a key intermediate in designing molecules with specific binding affinities. Molecular docking studies have demonstrated that this compound can effectively interact with various protein targets, including kinases and transcription factors. These interactions are critical for developing drugs that can modulate cellular signaling pathways associated with diseases such as cancer and neurodegenerative disorders.

The synthesis of< strong>5-hydroxypyrazine-2-carboxylic acid; sodium salt involves multi-step organic reactions that require precise control over reaction conditions. Researchers have reported efficient synthetic routes that minimize byproduct formation and maximize yield. These methods often involve catalytic hydrogenation, oxidation reactions, and salt formation steps, which are well-established in synthetic organic chemistry.

In terms of biological activity, preliminary studies have shown that< strong>5-hydroxypyrazine-2-carboxylic acid; sodium salt exhibits antioxidant properties. The hydroxyl group on the pyrazine ring can participate in redox reactions, helping to neutralize reactive oxygen species (ROS) that are implicated in oxidative stress-related diseases. This property makes it an attractive candidate for further investigation as a potential therapeutic agent for conditions such as aging-related disorders and cardiovascular diseases.

The< strong>sodium salt form also demonstrates interesting physicochemical properties that make it suitable for various applications beyond pharmaceuticals. For example, it can be used as a chelating agent in coordination chemistry, where it forms stable complexes with metal ions. These complexes have applications in catalysis, material science, and even in medical imaging techniques.

The growing interest in green chemistry has also prompted researchers to explore sustainable synthetic routes for< strong>5-hydroxypyrazine-2-carboxylic acid; sodium salt. Efforts have been made to develop processes that utilize renewable feedstocks and minimize waste generation. Such approaches align with global efforts to promote environmentally friendly chemical synthesis and reduce the ecological footprint of pharmaceutical manufacturing.

In conclusion, the< strong>5-hydroxypyrazine-2-carboxylic acid; sodium salt, identified by its CAS number CAS No. 77168-77-5, is a multifaceted compound with significant potential in pharmaceutical research and development. Its structural features, combined with its enhanced solubility and stability in the sodium salt form, make it a valuable intermediate for synthesizing novel therapeutic agents. Ongoing research continues to uncover new applications and benefits of this compound, reinforcing its importance in the field of medicinal chemistry.

• 13924-99-7(6-hydroxypyrazine-2-carboxylic acid)
• 73403-49-3(Sodium 1,6-Dihydro-6-oxo-2,3-pyrazinedicarboxylate)
• 34604-60-9(5-Hydroxypyrazine-2-carboxylic acid)
• 13924-95-3(Methyl 5-hydroxypyrazine-2-carboxylate)
• 1425842-17-6(3-Acetylamino-5-oxo-4,5-dihydro-pyrazine-2-carboxylic acid methyl ester)
• 77168-83-3(6-Methyl-5-oxo-4,5-dihydropyrazine-2-carboxylic acid)
• 77168-84-4(4,5-dihydro-6-methyl-5-oxo-2-Pyrazinecarboxylic acid methyl ester)
• 1503-03-3(3-Amino-5-hydroxy-pyrazine-2-carboxylic acid methyl ester)
• 54013-03-5(Ethyl 5-hydroxypyrazine-2-carboxylate)
• 73403-48-2(5-Hydroxypyrazine-2,3-dicarboxylic acid)